By Maggie Mertens The Government Accountability Office and the Food and Drug Administration are at it again. A report from GAO scolds FDA for not following up on studies for some drugs that get approved after data suggest they are effective on a marker
Read More...
Read the complete post at http://www.npr.org/blogs/health/2009/10/gao_faults_fda_over_lax_follow.html?ft=1&f=103537970
Posted
Oct 26 2009, 12:52 PM
by
NPR Blogs: NPR Health